enGene Therapeutics Inc. (ENGN) Earnings Call Transcripts
About enGene Therapeutics Inc.
enGene Therapeutics Inc. (ENGN) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning September 26, 2024 to September 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 7 enGene Therapeutics Inc. earnings call transcripts on record, spanning September 26, 2024 to September 14, 2026. Based on this history, enGene Therapeutics Inc. reports semi-annually. The most recent call on file is dated September 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- ENGN
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 7
- First call
- September 26, 2024
- Most recent
- September 14, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Company Conference Presentations | Sep 14, 2026 | Read transcript → |
| Special Calls | Aug 11, 2026 | Read transcript → |
| Special Calls | May 7, 2026 | Read transcript → |
| Company Conference Presentations | Mar 10, 2026 | Read transcript → |
| Special Calls | Nov 11, 2025 | Read transcript → |
| Company Conference Presentations | Sep 10, 2025 | Read transcript → |
| Special Calls | Sep 26, 2024 | Read transcript → |